The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa

The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa
复制标题

撒哈拉以南非洲低收入国家治疗慢性阻塞性肺病的并发症

DOI:
10.1080/17476348.2018.1423964
复制
发表时间:
2018
影响因子:
3.9
通讯作者:
T. van der Molen
T. van der Molen
中科院分区:
医学3区
文献类型:
--
作者:
F. V. van Gemert;B. Kirenga;T. Gebremariam;G. Nyale;C. De Jong;T. van der Molen

文献摘要

被引文献

相似文献

摘要简介:在大多数低收入和中等收入国家,慢性阻塞性肺疾病(COPD)呈上升趋势。覆盖领域:不幸的是,COPD在这些国家是一种被忽视的疾病。以撒哈拉以南非洲为例,在农村地区,COPD在公众意识和公共卫生规划方面甚至是未知的。COPD的管理方案开发不足,护理质量通常较低。吸入式药物往往无法获得或负担不起。吸烟是COPD最常见的危险因素。然而,在撒哈拉以南非洲,家庭空气污染是COPD发展的另一个主要风险因素。社区还面临各种其他风险因素,如出生体重不足、营养不良、儿童严重呼吸道感染、职业暴露、户外污染、人体免疫缺陷病毒和结核病。所有这些因素都造成撒哈拉以南非洲呼吸系统健康状况不佳的沉重负担。专家评论:慢性阻塞性肺疾病的流行似乎正在悄然蔓延。因此,预防和干预方案必须让所有利益攸关方参与,并尽早开始。需要更多的研究来描述,定义和告知治疗方法,以及生物质相关COPD的自然史。
ABSTRACT Introduction: In most low and middle-income countries, chronic obstructive pulmonary disease (COPD) is on the rise. Areas covered: Unfortunately, COPD is a neglected disease in these countries. Taking sub-Saharan Africa as an example, in rural areas, COPD is even unknown regarding public awareness and public health planning. Programs for the management of COPD are poorly developed, and the quality of care is often of a low standard. Inhaled medication is often not available or not affordable. Tobacco smoking is the most common encountered risk factor for COPD. However, in sub-Saharan Africa, household air pollution is another major risk factor for the development of COPD. Communities are also exposed to a variety of other risk factors, such as low birth weight, malnutrition, severe childhood respiratory infections, occupational exposures, outdoor pollution, human-immunodeficiency virus and tuberculosis. All these factors contribute to the high burden of poor respiratory health in sub-Saharan Africa. Expert commentary: A silent growing epidemic of COPD seems to be unravelling. Therefore, prevention and intervention programs must involve all the stakeholders and start as early as possible. More research is needed to describe, define and inform treatment approaches, and natural history of biomass-related COPD.